Collaboration Area ASU Investigators Partner Investigators Research Description
Alzheimer's Disease

Graciela Gonzalez, Ph.D.

Biomedical Informatics

Matthew Huentelman, Ph.D.

Neurogenomics

The Arizona Alzheimer's Disease Core Center (ADCC) is intended to capitalize on Arizona's scientific and organizational resources in the understanding, very early detection, and tracking of Alzheimer's disease (AD) and in the discovery of disease-slowing and prevention therapies

Autism

Joshua LaBaer, Ph.D.

Biodesign Institute

Matthew Huentelman, Ph.D.

Neurogenomics

Identify autoantibody signatures in autism on NAPPA

Biological Database Integration and Modeling

Seungchan Kim, Ph.D.

School of Computing & Informatics

Michael Bittner, Ph.D.

Computational Biology

Integrating genomic data and biological knowledge to learn context-specific gene networks

Cancer and Cell Biology

James Elser, Ph.D.

School of Life Sciences

Michael Berens, Ph.D.

Michael Barrett, Ph.D.

Cancer and Cell Biology

Biological stoichiometry and human cancer

Cancer and Cell Biology

Jeffrey Touchman, Ph.D.

School of Life Sciences

Jeffrey Trent, Ph.D.

Genetic Basis of Human Disease

Canine Hereditary Cancer Consortium

Cancer and Cell Biology

Seth Rose, Ph.D.

Chemistry/Biochemistry

Haiyong Han, Ph.D.

Clinical Translational Research

  • Testing anticancer compounds for synergy with the clinically used drug Paclitaxel
  • Develop a new drug that is effective against drug-resistant cancer cells
Diagnostics

Joshua LaBaer, Ph.D.

Biodesign Institute

Jeffrey Trent, Ph.D.

Genetic Basis of Human Disease

Autoantibody screening for autism

Diagnostics

Lee Cheatham, Ph.D.

Biodesign Institute

Michael Bittner, Ph.D.

Computational Biology

Integrated Biodosimetry System (IBiS) for high throughput medical care after radiologic and nuclear events

Diagnostics

Joshua LaBaer, Ph.D.

Biodesign Institute

Holly Yin, Ph.D.

Cellular Genomics

Fully automated platform that dramatically expands our capabilities to execute high-throughput cell based assays

Neurogenomics

Heather Bimonte-Nelson, Ph.D.

Psychology

Janet Neisewander, Ph.D.

School of Life Sciences

Matthew Huentelman, Ph.D.

Neurogenomics

Genetic variation in KIBRA and its role in human episodic memory

Neurogenomics

Heather Bimonte-Nelson, Ph.D.

Psychology

Matthew Huentelman, Ph.D.

Neurogenomics

Treatment for progressive cognitive impairment

Neurogenomics

Graciela Gonzalez, Ph.D.

Biomedical Informatics

Matthew Huentelman, Ph.D.

Neurogenomics

Application of gene prioritization methods to the selection of relevant targets for Alzheimer's disease

Neurogenomics

Valentin Dinu, Ph.D.

Biomedical Informatics

Matthew Huentelman, Ph.D.

David Craig, Ph.D.

Chris Kingsley, Ph.D.

Neurogenomics

Genetics of schizophrenia and Alzheimer’s disease

Pathogenesis

Valentin Dinu, Ph.D.

Biomedical Informatics

Sudhir Kumar, Ph.D.

Biodesign Institute

Paul Keim, Ph.D.

Mia Champion, Ph.D.

Pathogen Genomics

Genetic analysis methicillin-resistant staphylococcus aureus

Pathogenesis

Valentin Dinu, Ph.D.

Biomedical Informatics

Mia Champion, Ph.D.

Pathogen Genomics

Development of data repositories and analytical methods for pathogen and human high throughput genomic sequencing

Proteomics

Douglas Lake, Ph.D.

School of Life Sciences

Kostas Petritis, Ph.D.

Cheryl Selinsky, Ph.D.

Proteomics Center

Evaluation of the plasma peptidome and its correlation to the tumor proteome

Proteomics

Deirdre Meldrum, Ph.D.

Biodesign Institute

Jeffrey Trent, Ph.D.

Genetic Basis of Human Disease

Automation for high-throughput proteomics

Regenerative Medicine

Kenro Kusumi, Ph.D.

School of Life Sciences

Matthew Huentelman, Ph.D.

David Craig, Ph.D.

Neurogenomics

Examining the anolis transcriptome during tissue regeneration